Loading clinical trials...
Loading clinical trials...
The goal of this clinical trial is to learn if dihydroartemisinin (DHA) works to treat Androgenetic Alopecia (AGA) in female adults. The main question it aims to answer is: • Does DHA increase termin...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Shanghai Zhongshan Hospital
NCT07011485 · Alopecia, Androgenetic, Baldness, and more
NCT07076706 · Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA)
NCT07358403 · Androgenetic Alopecia (AGA), Chronic Telogen Effluvium
NCT07038941 · Male Pattern of Hair Loss, Androgenic Alopecia, Androgenetic Alopecia (AGA)
NCT07018349 · Androgenetic Alopecia (AGA)
Zhongshan Hospital Fudan University
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions